4.5 Review

Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence

Journal

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 18, Issue 2, Pages 259-272

Publisher

SPRINGER
DOI: 10.1007/s11154-017-9417-0

Keywords

Vitamin D; Cardiovascular; Mortality; Vitamin D receptor; Epidemiology; Cardiovascular risk; Review

Funding

  1. Amgen Switzerland AG
  2. Synlab Holding Deutschland Germany
  3. GmbH
  4. AMGEN
  5. BASF
  6. Sanofi
  7. Siemens Diagnostics
  8. Aegerion Pharmaceuticals
  9. Astrazeneca
  10. Danone Research
  11. Numares
  12. Pfizer
  13. Hoffmann LaRoche
  14. MSD, Alexion
  15. Abbott Diagnostics

Ask authors/readers for more resources

Vitamin D has long been established as an elemental factor of bone physiology. Beyond mineral metabolism, the expression of the vitamin D receptor has been identified throughout the cardiovascular (CV) system. Experimental studies showed beneficial effects of vitamin D on heart and vessels, but vitamin D intoxication in animals also led to hypercalcemia and vascular calcification. Our knowledge has been extended by epidemiological studies that showed that 25-hydroxyvitamin D (25(OH)D) levels are inversely associated with an increased CV risk itself, but also with established CV risk factors, such as arterial hypertension, endothelial dysfunction and atherosclerosis. Conversely, randomized controlled trials could not document significant and consistent effects of vitamin D supplementation on CV risk or events. Potential explanations may lie in differences in reference ranges or the possibility that low vitamin D in CV disease is only an epiphenomenon. In the latter case, the key question is why low 25(OH)D levels are such a strong predictor of health. While we wait for new data, the current conclusion is that vitamin D is a strong risk marker for CV risk factors and for CV diseases itself.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available